Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Goldenfelsstrasse 19-21, 50935 Cologne, Germany.
German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
J Antimicrob Chemother. 2021 Jun 18;76(7):1724-1730. doi: 10.1093/jac/dkab079.
To determine the most common tigecycline resistance mechanisms in carbapenem-resistant Acinetobacter baumannii isolates obtained during the global Tigecycline Evaluation Surveillance Trial (TEST).
Tigecycline MICs were determined by broth microdilution. WGS was used to screen for the previously identified tigecycline resistance mechanisms, as well as mutations in resistance-nodulation-cell division (RND)-type efflux pump regulators.
From a total 313 isolates, 113 genetically unique tigecycline-resistant isolates were analysed. The most frequent and worldwide distributed mechanism associated with tigecycline resistance was disruption of adeN, which encodes the repressor of the RND efflux pump AdeIJK, either by IS elements or nucleotide deletions causing premature stop codons. However, mutations leading to amino acid substitutions and disruption by IS elements within the two-component regulatory system adeRS, which regulates expression of the AdeABC efflux pump, correlate with higher tigecycline MICs, but these were found less frequently and were mainly restricted to Southern European countries. Furthermore, an altered version of tviB was identified in several tigecycline-resistant isolates that did not have putative resistance mutations within RND-type regulators. The resistance determinants tet(A) and tet(X), as well as resistance mutations in putative resistance determinants trm, plsC, rrf, msbA and genes encoding 30S ribosomal proteins, were not identified in any isolate.
The most prevalent tigecycline resistance mechanisms were caused by alterations in the regulators of RND-type efflux pumps. These data provide the basis for further characterization of regulator alterations and their contribution to increased efflux and tigecycline resistance, and also should be taken into account in drug discovery programmes to overcome the contribution of efflux pumps.
在全球替加环素评价监测试验(TEST)中,确定获得的耐碳青霉烯鲍曼不动杆菌分离株中最常见的替加环素耐药机制。
采用肉汤微量稀释法测定替加环素 MIC。使用 WGS 筛选先前鉴定的替加环素耐药机制,以及耐药性-结节-分裂(RND)型外排泵调节剂的突变。
在总共 313 株分离株中,分析了 113 株遗传上独特的替加环素耐药分离株。与替加环素耐药相关的最常见且分布广泛的机制是 adeN 的破坏,adeN 编码 RND 外排泵 AdeIJK 的抑制剂,要么是通过 IS 元件,要么是核苷酸缺失导致提前终止密码子。然而,导致氨基酸取代和 IS 元件内两成分调节系统 adeRS 破坏的突变与更高的替加环素 MIC 相关,但这些突变较少见,主要局限于南欧国家。此外,在几个替加环素耐药分离株中鉴定出 tviB 的改变版本,这些分离株在 RND 型调节剂内没有假定的耐药突变。tet(A)和 tet(X)耐药决定子以及假定的耐药决定子 trm、plsC、rrf、msbA 和编码 30S 核糖体蛋白的基因中的耐药突变在任何分离株中均未鉴定到。
最常见的替加环素耐药机制是由 RND 型外排泵调节剂的改变引起的。这些数据为进一步表征调节剂改变及其对增加外排和替加环素耐药性的贡献提供了基础,也应在药物发现计划中考虑到这些数据,以克服外排泵的贡献。